Masimo Appoints Tim Benner President
Analysis based on 8 articles · First reported Aug 03, 2026 · Last updated Aug 04, 2026
The appointment is a routine leadership change within a subsidiary of Danaher Corporation, likely to have minimal direct impact on Danaher's stock price. It signals continuity and stability in Masimo's management following its acquisition by Danaher, which may be viewed slightly positively by investors.
Masimo, a Danaher company and specialty diagnostics innovator, announced the appointment of Tim Benner as President, effective August 3, 2026. Benner, who joined Masimo in June 2025, previously served as Chief Marketing and Strategy Officer and most recently as Chief Commercial Officer. He brings over 30 years of executive leadership in medical technology, with prior roles at Edwards Lifesciences, Abbott, Terumo, Inari Medical/Stryker, and Masimo. Julie Sawyer Montgomery, CEO Designate of Danaher Corporation, expressed confidence in Benner's leadership. As President, Benner will lead Masimo's global business, focusing on innovation, customer partnerships, and commercial growth.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard